分析和贝叶斯估计的模型,用于 Chikungunya 动态与复发:在墨西哥阿卡普尔科,墨西哥的爆发
María Guadalupe Vázquez-Peña1, Cruz Vargas-De-León2,3, Jorge Fernando Camacho-Pérez4
1Facultad de Ciencias Físico-Matemáticas, Benemérita Universidad Autónoma de Puebla, Puebla, México.
Mathematical biosciences and engineering : MBE
|December 5, 2023
概括
奇孔古尼亚病毒传播模式现在包括感染复发. 数学模型显示,无症状感染对疾病传播和控制策略产生重大影响.
科学领域:
- 流行病学 流行病学
- 数学生物学 数学生物学
- 病毒学 病毒学
背景情况:
- 奇孔古尼亚是一种蚊子传播的病毒性疾病,没有特定的治疗或疫苗.
- 最近的数据显示,小孔古尼亚感染可能会在三个月内复发.
- 现有的数学模型无法解释这种复发现象.
研究的目的:
- 为了开发一种新的数学模型,用于 Chikungunya 病毒的传播,包括感染复发.
- 分析所提出模型的流行病学动态和稳定性.
- 将模型与现实世界的疫情数据相匹配,并估计关键参数.
主要方法:
- 使用下一代运算符方法计算基本生殖数 ($R_0$).
- 运用利亚普诺夫函数方法来确定平衡点的存在和总体稳定性.
- 应用贝叶斯方法与哈密尔顿蒙特卡洛方法进行参数估计,使用来自墨西哥阿卡普尔科的疫情数据.
主要成果:
- 这项研究成功开发并分析了一种数学模型,用于复发的奇昆古尼亚传播.
- 敏感性分析表明,无症状感染的比例显著影响基本生殖数 ($R_0$).
- 这些发现表明,由于无症状传播,某些控制措施可能不那么有效.
结论:
- 无症状感染的比例是一个关键因素,必须在奇孔尼亚控制策略中考虑.
- 开发的数学模型提供了对 Chikungunya 流行病学的更全面的理解.
- 将复发纳入模型对于准确的疾病预测和有效的公共卫生干预至关重要.
相关概念视频
Steps in Outbreak Investigation
133
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
133
Statistical Methods for Analyzing Epidemiological Data
372
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
372
Causality in Epidemiology
428
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
428
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
72
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
72
Mechanistic Models: Compartment Models in Individual and Population Analysis
43
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
43
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
136
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
136


